Lucchino L, Mallone F, Gharbiya M, Alisi L
Acta Neuropathol. 2024; 148(1):22.
PMID: 39150563
DOI: 10.1007/s00401-024-02783-1.
Matsuo T, Nishida K, Tanaka T, Seno T, Yamada K, Ono S
BMC Ophthalmol. 2024; 24(1):341.
PMID: 39138420
PMC: 11321082.
DOI: 10.1186/s12886-024-03604-5.
Ahmadova N, Kayabasi M, Koksaldi S, Humaz E, Saatci A
Turk J Ophthalmol. 2024; 54(3):140-148.
PMID: 38940356
PMC: 11589307.
DOI: 10.4274/tjo.galenos.2024.48017.
Estrela T, Truong S, Garcia A, He J, Ying G, Devakandan K
J Neuroophthalmol. 2024; 44(1):5-9.
PMID: 38252486
PMC: 10922160.
DOI: 10.1097/WNO.0000000000002075.
Papasavvas I, Herbort Jr C
Saudi J Ophthalmol. 2023; 37(3):250-255.
PMID: 38074305
PMC: 10701154.
DOI: 10.4103/sjopt.sjopt_218_22.
Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1.
Mallone F, Alisi L, Lucchino L, Di Martino V, Nebbioso M, Armentano M
Int J Mol Sci. 2023; 24(17).
PMID: 37686284
PMC: 10488231.
DOI: 10.3390/ijms241713481.
An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1.
Mallone F, Lucchino L, Giustini S, Lambiase A, Moramarco A
Orphanet J Rare Dis. 2022; 17(1):223.
PMID: 35698197
PMC: 9195315.
DOI: 10.1186/s13023-022-02369-8.
Neuroretinal dysfunction in patients affected by neurofibromatosis type 1.
Moramarco A, Lucchino L, Mallone F, Marcelli M, Alisi L, Roberti V
Int J Ophthalmol. 2022; 15(5):773-779.
PMID: 35601162
PMC: 9091878.
DOI: 10.18240/ijo.2022.05.13.
Choroidal Abnormalities in Pediatric NF1: A Cohort Natural History Study.
Cosmo E, Frizziero L, Miglionico G, De Biasi C, Bruno M, Trevisson E
Cancers (Basel). 2022; 14(6).
PMID: 35326581
PMC: 8946817.
DOI: 10.3390/cancers14061423.
Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.
Moramarco A, Mallone F, Sacchetti M, Lucchino L, Miraglia E, Roberti V
Orphanet J Rare Dis. 2021; 16(1):147.
PMID: 33757576
PMC: 7986306.
DOI: 10.1186/s13023-021-01773-w.
Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1.
Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Iacovino C
Graefes Arch Clin Exp Ophthalmol. 2018; 256(2):307-311.
PMID: 29290016
DOI: 10.1007/s00417-017-3870-z.
Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1.
Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J
Case Rep Ophthalmol. 2017; 8(1):214-220.
PMID: 28512424
PMC: 5422752.
DOI: 10.1159/000469702.
Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1.
Abdolrahimzadeh S, Felli L, Piraino D, Mollo R, Calvieri S, Recupero S
BMC Ophthalmol. 2014; 14:146.
PMID: 25424184
PMC: 4258815.
DOI: 10.1186/1471-2415-14-146.
Enhanced depth imaging spectral-domain optical coherence tomography findings in choroidal neurofibromatosis.
Rao R, Choudhry N
Ophthalmic Surg Lasers Imaging Retina. 2014; 45(5):466-8.
PMID: 25153660
PMC: 4398345.
DOI: 10.3928/23258160-20140818-01.
Optical coherence tomography imaging of choroidal abnormalities in neurofibromatosis type 1.
Makino S, Tampo H
Case Rep Ophthalmol Med. 2013; 2013:292981.
PMID: 23710396
PMC: 3654718.
DOI: 10.1155/2013/292981.
Indocyanine green angiographic findings of obscure choroidal abnormalities in neurofibromatosis.
Byun Y, Park Y
Korean J Ophthalmol. 2012; 26(3):230-4.
PMID: 22670083
PMC: 3364438.
DOI: 10.3341/kjo.2012.26.3.230.
Clinical and genetic patterns of neurofibromatosis 1 and 2.
Ragge N
Br J Ophthalmol. 1993; 77(10):662-72.
PMID: 8218038
PMC: 504612.
DOI: 10.1136/bjo.77.10.662.